Search research articles
Contact Us
Filters
Showing results (331-340 of 359) with videos related to
Page
of 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients
A Baars, A M Claessen, A J van den Eertwegh, et al.
Cancer Research
|
June 1, 1997
FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations
K M Fong, E J Biesterveld, A Virmani, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
J R Kroep, E F Smit, G Giaccone, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 3, 2013
Reproducibility of the WHO classification of thymomas: practical implications
P A Zucali, L Di Tommaso, I Petrini, et al.
Journal of Neuropathology and Experimental Neurology
|
June 22, 1999
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
O Bugiani, J R Murrell, G Giaccone, et al.
British Journal of Cancer
|
December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
M I Galleges Ruiz, K Floor, S M Steinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 1996
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP
B Ghetti, P Piccardo, M G Spillantini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer
A H Honkoop, E van der Wall, N Feller, et al.
The Oncologist
|
May 25, 1999
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer
A H Honkoop, S A Luykx-de Bakker, K Hoekman, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 359) with videos related to
Sort By:
Page
of 36
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)
M E R O'Brien, T Splinter, E F Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients
A Baars, A M Claessen, A J van den Eertwegh, et al.
Cancer Research
|
June 1, 1997
FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations
K M Fong, E J Biesterveld, A Virmani, et al.
Cancer Chemotherapy and Pharmacology
|
March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer
J R Kroep, E F Smit, G Giaccone, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 3, 2013
Reproducibility of the WHO classification of thymomas: practical implications
P A Zucali, L Di Tommaso, I Petrini, et al.
Journal of Neuropathology and Experimental Neurology
|
June 22, 1999
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
O Bugiani, J R Murrell, G Giaccone, et al.
British Journal of Cancer
|
December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
M I Galleges Ruiz, K Floor, S M Steinberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 23, 1996
Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP
B Ghetti, P Piccardo, M G Spillantini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Multiple cycles of high-dose doxorubicin and cyclophosphamide with G-CSF mobilized peripheral blood progenitor cell support in patients with metastatic breast cancer
A H Honkoop, E van der Wall, N Feller, et al.
The Oncologist
|
May 25, 1999
Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer
A H Honkoop, S A Luykx-de Bakker, K Hoekman, et al.
Page
of 36